unresectable liver cancer

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Bookmark

This academic research paper from The New England Journal of Medicine reports results from a clinical trial in which a treatment that combines the drugs atezolizumab and bevacizumab improved both progression-free and overall survival for people with unresectable primary liver cancer.

.